{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T11:15:49Z","timestamp":1793531749794,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA044479"],"award-info":[{"award-number":["DA044479"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA046526"],"award-info":[{"award-number":["DA046526"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA049130"],"award-info":[{"award-number":["DA049130"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA055879"],"award-info":[{"award-number":["DA055879"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA058933"],"award-info":[{"award-number":["DA058933"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007472","name":"University of Kentucky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007472","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.neuropharm.2023.109816","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T07:47:34Z","timestamp":1703058454000},"page":"109816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Impacts of xylazine on fentanyl demand, body weight, and acute withdrawal in rats: A comparison to lofexidine"],"prefix":"10.1016","volume":"245","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4169-4806","authenticated-orcid":false,"given":"Safiyah M.","family":"Sadek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailesh N.","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Kipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly E.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua S.","family":"Beckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8502-0160","authenticated-orcid":false,"given":"William W.","family":"Stoops","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Terry D.","family":"Hinds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2372-9323","authenticated-orcid":false,"given":"Cassandra D.","family":"Gipson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2023.109816_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.110993","article-title":"Xylazine potentiates the lethal but not the rewarding effects of fentanyl in mice","volume":"253","author":"Acosta-Mares","year":"2023","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2023.109816_bib2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/jps.21401","article-title":"Pharmacokinetics of lofexidine hydrochloride in healthy volunteers","volume":"98","author":"Al-Ghananeem","year":"2009","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.neuropharm.2023.109816_bib3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/ADM.0000000000001185","article-title":"Fentanyl absorption, distribution, metabolism, and excretion: narrative review and clinical significance related to illicitly manufactured fentanyl","volume":"17","author":"Bird","year":"2023","journal-title":"J. Addiction Med."},{"key":"10.1016\/j.neuropharm.2023.109816_bib4","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.peptides.2004.01.006","article-title":"Endogenous opioids and feeding behavior: a 30-year historical perspective","volume":"25","author":"Bodnar","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2023.109816_bib5","doi-asserted-by":"crossref","first-page":"R723","DOI":"10.1152\/ajpregu.00669.2004","article-title":"Brown adipose tissue thermogenesis contributes to fentanyl-evoked hyperthermia","volume":"288","author":"Cao","year":"2005","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.neuropharm.2023.109816_bib6","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0306-4522(02)00542-0","article-title":"Alpha2-adrenoceptor activation increases a cationic conductance and spontaneous GABAergic synaptic activity in dopaminergic neurones of the rat substantia nigra","volume":"115","author":"Cathala","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2023.109816_bib7","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00213-023-06390-y","article-title":"Xylazine effects on opioid-induced brain hypoxia","volume":"240","author":"Choi","year":"2023","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109816_bib8","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejphar.2017.02.017","article-title":"Role of A(1) and A(2A) adenosine receptor agonists in adipose tissue inflammation induced by obesity in mice","volume":"799","author":"DeOliveira","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109816_bib9","year":"2022"},{"key":"10.1016\/j.neuropharm.2023.109816_bib10","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1124\/jpet.119.258004","article-title":"Non-opioid neurotransmitter systems that contribute to the opioid withdrawal syndrome: a review of preclinical and human evidence","volume":"371","author":"Dunn","year":"2019","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2023.109816_bib11","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1038\/s41386-019-0420-x","article-title":"The role of orexin-1 receptor signaling in demand for the opioid fentanyl","volume":"44","author":"Fragale","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109816_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109380","article-title":"Xylazine spreads across the US: a growing component of the increasingly synthetic and polysubstance overdose crisis","volume":"233","author":"Friedman","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2023.109816_bib13","article-title":"Establishing preclinical withdrawal syndrome symptomatology following heroin self-administration in male and female rats","author":"Gipson","year":"2020","journal-title":"Exp. Clin. Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2023.109816_bib14","series-title":"Integrating Public Health and Translational Basic Science to Address Challenges of Xylazine Adulteration of Fentanyl","author":"Gipson","year":"2023"},{"key":"10.1016\/j.neuropharm.2023.109816_bib15","first-page":"Cd002024","article-title":"Alpha\u2082-adrenergic agonists for the management of opioid withdrawal","author":"Gowing","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuropharm.2023.109816_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0014-2999(89)90765-6","article-title":"Clonidine modulates dopamine cell firing in rat ventral tegmental area","volume":"165","author":"Grenhoff","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109816_bib17","article-title":"Managing opioid withdrawal in an outpatient setting with lofexidine or clonidine","volume":"14","author":"Gripshover","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.neuropharm.2023.109816_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107804","article-title":"Changes in fentanyl demand following naltrexone, morphine, and buprenorphine in male rats","volume":"207","author":"Hammerslag","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2023.109816_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00213-007-1020-8","article-title":"Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse","volume":"197","author":"Haney","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109816_bib20","first-page":"480","article-title":"Lofexidine in combination with oral naltrexone for opioid use disorder relapse prevention: a pilot randomized, double-blind, placebo-controlled study","volume":"28","author":"Hermes","year":"2019","journal-title":"Am. J. Addict.\/American Academy of Psychiatrists in Alcoholism and Addictions"},{"key":"10.1016\/j.neuropharm.2023.109816_bib21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.drugalcdep.2016.07.026","article-title":"Rearing environment differentially modulates cocaine self-administration after opioid pretreatment: a behavioral economic analysis","volume":"167","author":"Hofford","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2023.109816_bib22","first-page":"51","article-title":"Behavioral effects of separate and combined administration of naloxone and d-amphetamine","volume":"189","author":"Holtzman","year":"1974","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2023.109816_bib23","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1037\/0033-295X.115.1.186","article-title":"Economic demand and essential value","volume":"115","author":"Hursh","year":"2008","journal-title":"Psychol. Rev."},{"key":"10.1016\/j.neuropharm.2023.109816_bib24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0091-3057(81)90280-X","article-title":"Opioid modulation of ingestive behavior","volume":"15","author":"Jalowiec","year":"1981","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2023.109816_bib25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/2049463720911986","article-title":"Basic opioid pharmacology - an update","volume":"14","author":"James","year":"2020","journal-title":"Br. J. Pain"},{"key":"10.1016\/j.neuropharm.2023.109816_bib26","doi-asserted-by":"crossref","first-page":"E249","DOI":"10.1152\/ajpendo.00478.2015","article-title":"The glucocorticoid receptor: cause of or cure for obesity?","volume":"310","author":"John","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2023.109816_bib27","first-page":"395","article-title":"Increasing presence of xylazine in heroin and\/or fentanyl deaths","volume":"27","author":"Johnson","year":"2021","journal-title":"Philadelphia, Pennsylvania"},{"key":"10.1016\/j.neuropharm.2023.109816_bib28","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1124\/mol.64.6.1317","article-title":"Functional interactions between mu opioid and alpha 2A-adrenergic receptors","volume":"64","author":"Jordan","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109816_bib29","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/BF00180844","article-title":"Effects of clonidine and morphine on opioid withdrawal in rhesus monkeys","volume":"88","author":"Katz","year":"1986","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2023.109816_bib30","article-title":"Xylazine suppresses fentanyl consumption during self-administration and induces a unique sex-specific withdrawal syndrome that is not altered by naloxone in rats","author":"Khatri","year":"2023","journal-title":"Exp. Clin. Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2023.109816_bib31","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1038\/s41366-022-01224-x","article-title":"Anti-obesity effects of the dual-active adenosine A(2A)\/A(3) receptor-ligand LJ-4378","volume":"46","author":"Kim","year":"2022","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.neuropharm.2023.109816_bib32","first-page":"1","article-title":"The use of clonidine in detoxification from opiates","volume":"32","author":"Kleber","year":"1980","journal-title":"Bull. Narc."},{"key":"10.1016\/j.neuropharm.2023.109816_bib33","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s00213-013-3298-z","article-title":"Effects of repeated exposure to morphine in adolescent and adult male C57BL\/6J mice: age-dependent differences in locomotor stimulation, sensitization, and body weight loss","volume":"231","author":"Koek","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2023.109816_bib34","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.drugalcdep.2013.07.032","article-title":"Differential effects of acute and chronic treatment with the alpha2-adrenergic agonist, lofexidine, on cocaine self-administration in rhesus monkeys","volume":"133","author":"Kohut","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2023.109816_bib35","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.phrs.2006.03.009","article-title":"Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome","volume":"53","author":"Langin","year":"2006","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2023.109816_bib36","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41598-023-27992-8","article-title":"Intravenous fentanyl self-administration in male and female C57BL\/6J and DBA\/2J mice","volume":"13","author":"Leonardo","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2023.109816_bib37","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/add.16100","article-title":"Fentanyl withdrawal: understanding symptom severity and exploring the role of body mass index on withdrawal symptoms and clearance","volume":"118","author":"Luba","year":"2023","journal-title":"Addiction"},{"key":"10.1016\/j.neuropharm.2023.109816_bib38","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0286-21.2022","article-title":"Ovarian hormones regulate nicotine consumption and accumbens glutamatergic plasticity in female rats","volume":"9","author":"Maher","year":"2022","journal-title":"eNeuro"},{"key":"10.1016\/j.neuropharm.2023.109816_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108756","article-title":"Natural and synthetic estrogens specifically alter nicotine demand and cue-induced nicotine seeking in female rats","volume":"198","author":"Maher","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109816_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.110983","article-title":"Synthetic contraceptive hormones occlude the ability of nicotine to reduce ethanol consumption in ovary-intact female rats","volume":"252","author":"Maher","year":"2023","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2023.109816_bib41","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00408180","article-title":"Tolerance to and physical dependence on morphine in rats","volume":"4","author":"Martin","year":"1963","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.neuropharm.2023.109816_bib42","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00213-017-4536-6","article-title":"Oxycodone self-administration in male and female rats","volume":"234","author":"Mavrikaki","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109816_bib43","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0091-3057(87)90584-3","article-title":"Factors controlling drug reinforced behavior","volume":"27","author":"Meisch","year":"1987","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2023.109816_bib44","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1523\/JNEUROSCI.4632-08.2009","article-title":"Adrenergic and noradrenergic innervation of the midbrain ventral tegmental area and retrorubral field: prominent inputs from medullary homeostatic centers","volume":"29","author":"Mejias-Aponte","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109816_bib45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.exger.2010.10.004","article-title":"Effects of chronic fentanyl administration on physical performance of aged rats","volume":"46","author":"Mitzelfelt","year":"2011","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.neuropharm.2023.109816_bib46","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/nn1578","article-title":"Is there a common molecular pathway for addiction?","volume":"8","author":"Nestler","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109816_bib47","first-page":"1035","article-title":"Anesthesia in the Richardson's ground squirrel: comparison of ketamine, ketamine and xylazine, droperidol and fentanyl, and sodium pentobarbital","volume":"189","author":"Olson","year":"1986","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.neuropharm.2023.109816_bib48","first-page":"140","article-title":"Changing landscape of fentanyl\/heroin use and distribution","volume":"53","author":"Pesce","year":"2023","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.neuropharm.2023.109816_bib49","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1360-0443.1998.9333212.x","article-title":"Polydrug abuse in heroin addicts: a behavioral economic analysis","volume":"93","author":"Petry","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.neuropharm.2023.109816_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108020","article-title":"Nicotine reduction does not alter essential value of nicotine or reduce cue-induced reinstatement of nicotine seeking","volume":"212","author":"Powell","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2023.109816_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4236\/pp.2019.101001","article-title":"Differences in the receptor binding profile of lofexidine compared to clonidine","volume":"10","author":"Raffa","year":"2019","journal-title":"Pharmacol. Pharm."},{"key":"10.1016\/j.neuropharm.2023.109816_bib52","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0091-3057(89)90293-1","article-title":"Relationships between sustained sucrose-feeding and opioid tolerance and withdrawal","volume":"34","author":"Schoenbaum","year":"1989","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2023.109816_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.691700","article-title":"Impact of morphine dependence and withdrawal on the reinforcing effectiveness of fentanyl, cocaine, and methamphetamine in rats","volume":"12","author":"Seaman","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109816_bib54","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/vr.112.16.385-a","article-title":"Influence of some sedative drugs on the appetite of red deer","volume":"112","author":"Simpson","year":"1983","journal-title":"Vet. Rec."},{"key":"10.1016\/j.neuropharm.2023.109816_bib55","article-title":"Necrotic upper-extremity infections in people who inject drugs: a case series","author":"Soderquist","year":"2023","journal-title":"J. Hand Surg."},{"key":"10.1016\/j.neuropharm.2023.109816_bib56","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000001216","article-title":"Self-reported xylazine experiences: a mixed-methods study of reddit subscribers","author":"Spadaro","year":"2023","journal-title":"J. Addiction Med."},{"key":"10.1016\/j.neuropharm.2023.109816_bib57","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1097\/j.pain.0000000000001612","article-title":"The contribution of obesity to prescription opioid use in the United States","volume":"160","author":"Stokes","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2023.109816_bib58","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0091-3057(78)90037-0","article-title":"Tolerance and evidence of physical dependence to daily codeine injections in the rat","volume":"9","author":"Thornhill","year":"1978","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2023.109816_bib59","first-page":"120","article-title":"Changes in diurnal temperature and feeding patterns of rats during repeated injections of heroin and withdrawal","volume":"223","author":"Thronhill","year":"1976","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.neuropharm.2023.109816_bib60","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1038\/s41386-019-0356-1","article-title":"Sex differences in opioid reinforcement under a fentanyl vs. food choice procedure in rats","volume":"44","author":"Townsend","year":"2019","journal-title":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109816_bib61","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0165-1781(80)90005-0","article-title":"Clonidine suppresses the opioid abstinence syndrome without clonidine-withdrawal symptoms: a blind inpatient study","volume":"2","author":"Uhde","year":"1980","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2023.109816_bib62","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nchembio.64","article-title":"Conformational cross-talk between alpha2A-adrenergic and mu-opioid receptors controls cell signaling","volume":"4","author":"Vilardaga","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neuropharm.2023.109816_bib63","doi-asserted-by":"crossref","first-page":"66","DOI":"10.7589\/0090-3558-20.1.66","article-title":"Xylazine hydrochloride-induced anorexia in white-tailed deer","volume":"20","author":"Warren","year":"1984","journal-title":"J. Wildl. Dis."},{"key":"10.1016\/j.neuropharm.2023.109816_bib64","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/j.1875-9114.1981.tb03561.x","article-title":"Clonidine in opiate withdrawal: review and appraisal of clinical findings","volume":"1","author":"Washton","year":"1981","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.neuropharm.2023.109816_bib65","first-page":"481","article-title":"Comparison of ketamine-xylazine and ketamine-dexmedetomidine anesthesia and intraperitoneal tolerance in rats","volume":"52","author":"Wellington","year":"2013","journal-title":"J Am Assoc Lab Anim Sci"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823004069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823004069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T05:49:22Z","timestamp":1719985762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390823004069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":65,"alternative-id":["S0028390823004069"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109816","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impacts of xylazine on fentanyl demand, body weight, and acute withdrawal in rats: A comparison to lofexidine","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109816","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109816"}}